Summary: The Royal Surrey NHS Foundation Trust has opened a new Community Diagnostic Centre to provide thousands of additional scans per year, helping to detect serious illnesses earlier. Cera, a digital home healthcare provider, has reached 75 million patient visits since its launch in 2016, delivering over 2 million visits monthly. A team has received £1 million in funding for a clinical trial of a device designed to treat threatened miscarriage, aiming to improve patient care.
The technology, called Callavid, is designed to improve the delivery of progesterone medication via a small, tampon-shaped device with an integrated mini-liner. Progesterone medication is recommended under NICE guidelines for women who have suffered at least one prior miscarriage and subsequently face “threatened miscarriage”. (View Highlight)
remote monitoring system enables WAST clinicians to track patient health data in real time, enabling earlier interventions and more efficient use of NHS resources. (View Highlight)
AI could help by providing faster, more accurate decisions based on richer data and individual context, while freeing clinicians to focus on care. (View Highlight)
“AI Navigation Assistant” that works across the NHS, which would draw from integrated records and local care options to guide patients to the most appropriate services. (View Highlight)
